根据网络药理学,分子对接和分子动力学模拟,针对胃食道逆流病的素的机制
Xinyu Wang1, Changhong Yan2, Tong Wang1
1Inner Mongolia Medical University, Hohhot, China.
Cell biochemistry and biophysics
|August 24, 2024
概括
素显示出通过向关键通路来治疗胃食道逆流性疾病 (GERD) 的潜力. 这项研究使用了网络药理学和分子动力学来发现黄素.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 胃肠病学 胃肠病学
背景情况:
- 素是一种天然的黄类化合物,在中国传统医学中已经证明对胃食道逆流症 (GERD) 的疗效.
- 了解黄素在GERD治疗中的精确分子标和机制对于进一步的药物开发至关重要.
研究的目的:
- 为了确定黄素治疗GERD的潜在治疗点和作用机制.
- 为在GERD管理中提供卢特林临床应用的理论基础.
主要方法:
- 结合网络药理学和分子动力学模拟.
- 选药物和疾病目标,构建Venn图,并分析蛋白质-蛋白质相互作用 (PPI) 网络.
- 进行了基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径丰富分析,分子对接和分子动力学模拟.
主要成果:
- 确定了159个交叉标和10个核心标,用于治疗GERD中的黄素.
- 凯格分析显示TNF,IL-17,NF-kappa B和Toll类受体信号通路的丰富.
- 分子对接和动力学模拟证实了黄素与核心标的稳定结合,包括IL6.
结论:
- 网络药理学,分子对接和分子动力学模拟阐明了luteolin治疗GERD的治疗机制.
- 这些发现支持素作为GERD治疗的有前途药物,并为未来的研究奠定了基础.
相关概念视频
Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
410
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
410
Antiasthma Drugs: Leukotriene Modifiers
259
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
259
Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
298
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
298
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
377
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
377


